Understanding Biotech Risks
Richard discusses the high failure rates in Alzheimer's drug development and emphasizes the importance of understanding past failures to inform future innovations. He highlights the unique scientific risks associated with biotech, contrasting them with the more straightforward metrics of software companies. By digging into the history and mechanisms behind diseases, one can better assess whether new technologies hold promise.In this clip
From this podcast
The Hard Part with Evan McCann
Richard Waines from DCVC Bio
Related Questions